Optimization of a methamphetamine conjugate vaccine for antibody production in mice
- 1 June 2016
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 35, 137-141
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse of the National Institutes of Health (U01DA023900, U01DA035511)
- National Center for Advancing Translational Sciences (ULITR000039)
- Arkansas Biosciences Institute
This publication has 23 references indexed in Scilit:
- Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccineThe American Journal on Addictions, 2015
- Effects of active anti-methamphetamine vaccination on intravenous self-administration in ratsDrug and Alcohol Dependence, 2015
- Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierPLOS ONE, 2014
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvantVaccine, 2013
- A Methamphetamine Vaccine Attenuates Methamphetamine-Induced Disruptions in Thermoregulation and Activity in RatsBiological Psychiatry, 2013
- Vaccines Against Drug AbuseClinical Pharmacology & Therapeutics, 2011
- Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine ImmunotherapeuticClinical Pharmacology & Therapeutics, 2011
- Use of defined TLR ligands as adjuvants within human vaccinesImmunological Reviews, 2010
- The Synthesis of Haptens and Their Use for the Development of Monoclonal Antibodies for Treating Methamphetamine AbuseJournal of Medicinal Chemistry, 2009
- Human therapeutic cocaine vaccine: safety and immunogenicityVaccine, 2002